DE602005025042D1 - Hautpflegezubereitungen welche mupirocin und betamethason-dipropionat enthalten - Google Patents

Hautpflegezubereitungen welche mupirocin und betamethason-dipropionat enthalten

Info

Publication number: DE602005025042D1
Authority: DE; Germany
Prior art keywords: preparation; betamethasone dipropionate; activity against; therapeutic effect; skin care
Prior art date: 2005-09-02
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Active

Application number

DE602005025042T

Other languages

English (en)

Inventor

Gutierrez Manuel C P Soto

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Laboratorios Dermatologicos Darier SA de CV

Original Assignee

Laboratorios Dermatologicos Darier SA de CV

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2005-09-02

Filing date

2005-09-28

Publication date

2011-01-05

2005-09-28 Application filed by Laboratorios Dermatologicos Darier SA de CV filed Critical Laboratorios Dermatologicos Darier SA de CV

2011-01-05 Publication of DE602005025042D1 publication Critical patent/DE602005025042D1/de

Status Active legal-status Critical Current

2025-09-29 Anticipated expiration legal-status Critical

Links

238000002360 preparation method Methods 0.000 title abstract 6
MINDHVHHQZYEEK-UHFFFAOYSA-N (E)-(2S,3R,4R,5S)-5-[(2S,3S,4S,5S)-2,3-epoxy-5-hydroxy-4-methylhexyl]tetrahydro-3,4-dihydroxy-(beta)-methyl-2H-pyran-2-crotonic acid ester with 9-hydroxynonanoic acid Natural products CC(O)C(C)C1OC1CC1C(O)C(O)C(CC(C)=CC(=O)OCCCCCCCCC(O)=O)OC1 MINDHVHHQZYEEK-UHFFFAOYSA-N 0.000 title abstract 2
229960001102 betamethasone dipropionate Drugs 0.000 title abstract 2
CIWBQSYVNNPZIQ-XYWKZLDCSA-N betamethasone dipropionate Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@H](C)[C@@](C(=O)COC(=O)CC)(OC(=O)CC)[C@@]1(C)C[C@@H]2O CIWBQSYVNNPZIQ-XYWKZLDCSA-N 0.000 title abstract 2
229960003128 mupirocin Drugs 0.000 title abstract 2
229930187697 mupirocin Natural products 0.000 title abstract 2
MINDHVHHQZYEEK-HBBNESRFSA-N mupirocin Chemical compound C[C@H](O)[C@H](C)[C@@H]1O[C@H]1C[C@@H]1[C@@H](O)[C@@H](O)[C@H](C\C(C)=C\C(=O)OCCCCCCCCC(O)=O)OC1 MINDHVHHQZYEEK-HBBNESRFSA-N 0.000 title 1
230000000694 effects Effects 0.000 abstract 3
206010040872 skin infection Diseases 0.000 abstract 2
230000001225 therapeutic effect Effects 0.000 abstract 2
206010048768 Dermatosis Diseases 0.000 abstract 1
206010070834 Sensitisation Diseases 0.000 abstract 1
241000191940 Staphylococcus Species 0.000 abstract 1
241000194017 Streptococcus Species 0.000 abstract 1
230000001580 bacterial effect Effects 0.000 abstract 1
239000004359 castor oil Substances 0.000 abstract 1
235000019438 castor oil Nutrition 0.000 abstract 1
ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 abstract 1
230000002757 inflammatory effect Effects 0.000 abstract 1
239000002054 inoculum Substances 0.000 abstract 1
239000000203 mixture Substances 0.000 abstract 1
DDHVILIIHBIMQU-YJGQQKNPSA-L mupirocin calcium hydrate Chemical compound O.O.[Ca+2].C[C@H](O)[C@H](C)[C@@H]1O[C@H]1C[C@@H]1[C@@H](O)[C@@H](O)[C@H](C\C(C)=C\C(=O)OCCCCCCCCC([O-])=O)OC1.C[C@H](O)[C@H](C)[C@@H]1O[C@H]1C[C@@H]1[C@@H](O)[C@@H](O)[C@H](C\C(C)=C\C(=O)OCCCCCCCCC([O-])=O)OC1 DDHVILIIHBIMQU-YJGQQKNPSA-L 0.000 abstract 1
239000002674 ointment Substances 0.000 abstract 1
229920001223 polyethylene glycol Polymers 0.000 abstract 1
239000003755 preservative agent Substances 0.000 abstract 1
230000001823 pruritic effect Effects 0.000 abstract 1
230000009291 secondary effect Effects 0.000 abstract 1
230000008313 sensitization Effects 0.000 abstract 1
208000017520 skin disease Diseases 0.000 abstract 1
241000894007 species Species 0.000 abstract 1
230000000699 topical effect Effects 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/351—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom not condensed with another ring
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders

Landscapes

Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Dermatology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)

DE602005025042T 2005-09-02 2005-09-28 Hautpflegezubereitungen welche mupirocin und betamethason-dipropionat enthalten Active DE602005025042D1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
MXPA05009381A MXPA05009381A (es)	2005-09-02	2005-09-02	Preparaciones para el cuidado de la piel que contienen mupirocina y dipropionato de betametasona.
PCT/MX2005/000084 WO2007027077A1 (es)	2005-09-02	2005-09-28	Preparaciones para el cuidado de la piel que contienen mupirocina y dipropionato de betametasona

Publications (1)

Publication Number	Publication Date
DE602005025042D1 true DE602005025042D1 (de)	2011-01-05

Family

ID=37809109

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DE602005025042T Active DE602005025042D1 (de)	2005-09-02	2005-09-28	Hautpflegezubereitungen welche mupirocin und betamethason-dipropionat enthalten

Country Status (7)

Country	Link
US (1)	US8349889B2 (de)
EP (1)	EP1932525B1 (de)
AT (1)	ATE489084T1 (de)
DE (1)	DE602005025042D1 (de)
ES (1)	ES2357662T3 (de)
MX (1)	MXPA05009381A (de)
WO (1)	WO2007027077A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
MXPA05009381A (es)	2005-09-02	2007-03-01	Fernando Ahumada Ayala	Preparaciones para el cuidado de la piel que contienen mupirocina y dipropionato de betametasona.
US20160324872A1 (en) *	2014-01-08	2016-11-10	Mayo Foundation For Medical Education And Research	Impregnated dressings for treating dermatological disorders
CN113274346A (zh) *	2021-05-25	2021-08-20	满孝勇	一种莫匹罗星软膏的应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB8530796D0 (en)	1985-12-13	1986-01-22	Beecham Group Plc	Pharmaceutical composition
IL123143A (en) *	1998-02-02	2001-08-26	Agis Ind 1983 Ltd	Pharmaceutical compositions containing mupirocin
US6294192B1 (en) *	1999-02-26	2001-09-25	Lipocine, Inc.	Triglyceride-free compositions and methods for improved delivery of hydrophobic therapeutic agents
IL137363A (en)	2000-07-18	2005-12-18	Agis Ind 1983 Ltd	Pharmaceutical compositions containing mupirocin
AU9163701A (en) *	2000-10-27	2002-05-06	Leo Pharma As	Topical composition containing at least one vitamin D or one vitamin D analogue and at least one corticosteroid
MXPA05009381A (es)	2005-09-02	2007-03-01	Fernando Ahumada Ayala	Preparaciones para el cuidado de la piel que contienen mupirocina y dipropionato de betametasona.

2005
- 2005-09-02 MX MXPA05009381A patent/MXPA05009381A/es active IP Right Grant
- 2005-09-28 ES ES05787388T patent/ES2357662T3/es active Active
- 2005-09-28 WO PCT/MX2005/000084 patent/WO2007027077A1/es active Application Filing
- 2005-09-28 AT AT05787388T patent/ATE489084T1/de not_active IP Right Cessation
- 2005-09-28 US US12/065,352 patent/US8349889B2/en not_active Expired - Fee Related
- 2005-09-28 EP EP05787388A patent/EP1932525B1/de not_active Not-in-force
- 2005-09-28 DE DE602005025042T patent/DE602005025042D1/de active Active

Also Published As

Publication number	Publication date
ATE489084T1 (de)	2010-12-15
EP1932525B1 (de)	2010-11-24
EP1932525A1 (de)	2008-06-18
ES2357662T3 (es)	2011-04-28
US20100063015A1 (en)	2010-03-11
WO2007027077A1 (es)	2007-03-08
MXPA05009381A (es)	2007-03-01
US8349889B2 (en)	2013-01-08

Similar Documents

Publication	Publication Date	Title
EP1362581B1 (de)	2010-11-24	Kosmetische Grundierung enthaltend eine Kombination aus schweisshemmenden und antimikrobiellen Wirkstoffen
BR112015014118A2 (pt)	2017-07-11	método para prevenção e/ou tratamento de infecções, colonizações ou doenças relacionadas com staphylococcus aureus, pseudomonas aeruginosa, streptococcus pyogenes, enterococcus faecium, enterobacter cloacae, proteus mirabilis, bacteroides fragilis, staphylococcus epidermidis, propionibacterium acnes, candida albicans e/ou malassezia furfur
WO2014153238A3 (en)	2015-03-12	Compositions, methods and devices for promoting wound healing and reducing infection
BR112014026058A2 (pt)	2017-06-27	composições para tratamento tópico de infecções microbianas
WO2012017349A3 (en)	2012-08-02	Topical pharmaceutical composition comprising nanonized silver sulfadiazine and chlorhexidine gluconate
WO2010124280A3 (en)	2011-02-10	Human serum albumin-based topical ointment for treatment of acne, psoriasis, egfr-induced toxicity, premature skin aging and other skin conditions
WO2012026766A3 (ko)	2012-06-07	신규한 헤테로고리 화합물 및 이를 이용한 염증성 질환 치료용 조성물
AU2003241345A1 (en)	2003-11-17	Use of mastic and its components for the control of microbial infections
MX2024000828A (es)	2024-02-08	Formulaciones de parasiticida de isoxazolina y metodos para el tratamiento de la blefaritis.
WO2019035705A3 (es)	2019-05-09	Composición tópica semisólida conteniendo un agente antimicrobiano y pirfenidona para el tratamiento de daños crónicos de la piel
WO2016159593A3 (ko)	2016-11-24	락토코커스 중앙젠시스를 유효성분으로 함유하는 염증성 질환의 예방 또는 치료용 약학적 조성물
AR065317A1 (es)	2009-05-27	Uso de quitosanos, derivados de quitosanos y una sal fisiologicamente aceptable del mismo para el tratamiento de enfermedades inflamatorias ungueales
WO2018176093A8 (en)	2018-11-15	Berberine alkaloid formulations in the prevention and/or treatment of infectious disease
WO2021046315A3 (en)	2021-04-22	Inhibitors of encephalitic alphaviruses
PL1893237T3 (pl)	2010-02-26	Kompozycja farmaceutyczna zawierająca elastomer poliorganosiloksanowy i solubilizowany składnik aktywny
PH12012502173A1 (en)	2013-02-04	Topical pharmaceutical compositions comprising mometasone furoate
DE602006003224D1 (de)	2008-11-27	Substituierte heterocyclen, ihre verwendung als medikament und pharmazeutische zubereitungen, die sie enthalten
ATE489084T1 (de)	2010-12-15	Hautpflegezubereitungen welche mupirocin und betamethason-dipropionat enthalten
WO2014070696A3 (en)	2014-10-09	Treatment of chronic dermal inflammatory with norketotifen
BRPI0417116A (pt)	2007-03-06	usos de uma quantidade eficaz de ondansetron e composição para tratamento tópico de uma inflamação
MX2023005658A (es)	2023-09-07	Formulaciones de gel, ungüento y espuma de tapinarof y metodos de uso.
WO2007082864A3 (en)	2008-02-07	Use of chavicol as an antiseptic
SG11201909144VA (en)	2019-11-28	Bacterial secretome for use in the treatment of skin lesions
DE602004031964D1 (de)	2011-05-05	Ndlung von dermatologischen erkrankungen
MX2023010872A (es)	2023-09-28	Nueva composición tópica libre de tensioactivos derivados de sulfato.